XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash from operating activities    
Net income (loss) $ (7,407) $ (5,174)
Non-cash and non-operating items 42,706 122,043
- Amortization and provisions 56,288 134,650
- Payment for contingent liability on regulatory matters (43,334) 0
- Net (gain) or loss on disposal of non-current assets (8,903) (361)
- Equity awards compensation expense [1] 76,353 42,594
- Interest accrued and non-cash financial income and expenses 0 (2,244)
- Change in deferred taxes (24,742) (16,051)
- Change in income taxes (18,007) (12,899)
- Other 5,051 (23,646)
Changes in working capital related to operating activities 27,607 13,661
- (Increase) / Decrease in trade receivables 78,890 75,399
- Increase / (Decrease) in trade payables (71,190) (19,526)
- (Increase) / Decrease in other current assets 1,968 (23,224)
- Increase/ (Decrease) in other current liabilities 17,926 (20,178)
- Change in operating lease liabilities and right of use assets 13 1,190
Cash from operating activities 62,906 130,530
Cash (used for) from investing activities    
Acquisition of intangible assets, property, plant and equipment (77,838) (48,955)
Change in accounts payable related to intangible assets, property, plant and equipment (16,749) 7,632
Payment for business, net of cash acquired (6,957) (135,453)
Proceeds from disposition of investments 9,625 0
Change in other non-current financial assets (12,280) 43,052
Cash (used for) from investing activities (104,199) (133,724)
Cash used for financing activities    
Proceeds from borrowings under line-of-credit agreement 0 78,513
Repayment of borrowings 0 (78,513)
Proceeds from exercise of stock options 1,948 617
Repurchase of treasury stocks (103,354) (59,162)
Change in other financial liabilities 0 107
Cash payment for contingent consideration (22,025) 0
Other [2] (1,427) 22,242
Cash used for financing activities (124,858) (36,196)
Effect of exchange rates changes on cash and cash equivalents (12,192) (68,813)
Net increase (decrease) in cash and cash equivalents (178,343) (108,203)
Net cash and cash equivalents at beginning of period 448,200 515,526
Net cash and cash equivalents and restricted cash at end of period 269,857 407,323
Supplemental disclosures of cash flow information    
Cash paid for taxes, net of refunds (41,377) (33,685)
Cash paid for interest $ (1,055) $ (959)
[1] Of which $74.9 million and $41.1 million of equity awards compensation expense consisted of share-based compensation expense according to ASC 718 Compensation - stock compensation for the nine months ended September 30, 2023 and 2022, respectively.
[2] Primarily consists of realized gains in FX hedges for the nine months ended September 30, 2022.